Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for inducing direct reprogramming of urine cells into renal progenitor cells and pharmaceutical composition for preventing or treating renal cell injury disease comprising renal progenitor cells reprogrammed by same method

A urine cell, reprogramming technology, applied in drug combinations, urinary system diseases, urinary tract/kidney cells, etc., can solve problems such as expanding kidney damage

Pending Publication Date: 2022-04-22
KOREA UNIV RES & BUSINESS FOUND
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This not only amplifies kidney damage, but also puts patients with kidney failure at risk for cardiovascular disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inducing direct reprogramming of urine cells into renal progenitor cells and pharmaceutical composition for preventing or treating renal cell injury disease comprising renal progenitor cells reprogrammed by same method
  • Method for inducing direct reprogramming of urine cells into renal progenitor cells and pharmaceutical composition for preventing or treating renal cell injury disease comprising renal progenitor cells reprogrammed by same method
  • Method for inducing direct reprogramming of urine cells into renal progenitor cells and pharmaceutical composition for preventing or treating renal cell injury disease comprising renal progenitor cells reprogrammed by same method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] Example 1: Isolation of urine cells from urine

[0097] The method for isolating urine cells from urine is based on the technique developed by Sutherland and Bain in England in 1972, as follows.

[0098] First, 1000 g of urine provided by the donor is centrifuged for 10 minutes. After removing the supernatant, the pellet remaining in the lower layer was diluted in 20 mL of PBS solution containing antibiotics such as 1% penicillin / streptomycin / amphotericin B. Then, the diluted PBS + pellet solution was centrifuged at a total of 1000g for 10 minutes. After removing the supernatant, dilute the remaining pellet in the lower layer with 1 mL of DMEM / F12-based basal medium containing 1% penicillin / streptomycin / amphotericin B, 1% L-glutamine, and 10% FBS, and seeded in gelatin-coated 12-well cell culture plates. After that, after adding 1 mL of basal medium and culturing for 3 days, the resulting cells were cultured by changing the basal medium to a growth medium prepared by...

Embodiment 2

[0099] Example 2: Introduction of reprogramming factors into urine cells

[0100] Using the retroviral packaging cell line 293GPG derived from human 293, by introducing a combination of reprogramming factors into the vectors pMXs-Oct4, pMXs-Klf4, pMXs-Sox2, pMXs-cMyc, pMXs-Slug, pMXs-Six1, pMXs-Six2 , pMXs-Osr1, pMXs-Pax2 and pMXs-Eya1 to prepare the vector, the vector pMXs-Oct4, pMXs-Klf4, pMXs-Sox2, pMXs-cMyc, pMXs-Slug, pMXs-Six1, pMXs-Six2, pMXs-Osr1 , pMXs-Pax2 and pMXs-Eya1 were prepared by inserting the nucleotide sequences encoding Oct4, Klf4, Sox2, c-Myc, Slug, Six1, Six2, Osr1, Pax2 and Eya1 proteins into pMXs vector respectively. Using Lipofectamine 2000 (Life Technologies), the reprogramming factor-introduced combination vector was injected into the urine-derived cells isolated and cultured in Example 1 to prepare reprogramming factor-introduced urine cells.

[0101] Urine cells that introduce reprogramming factors are based on a 1:1 mixed medium of DMEM and REGM ...

Embodiment 3

[0102] Example 3: Induction of urine-derived reprogrammed renal progenitor cells

[0103] The urine-derived cells introduced with reprogramming factors were seeded on Matrigel-coated cell culture plates, and then added to Advanced RPMI 1640 medium (Gibco) containing 1 μg / ml heparin, 125 nM LDN-193189 and 0.5% L-glutamine. In the renal progenitor cell induction and expansion medium supplemented with 100ng / ml FGF9, 30ng / ml BMP7, 1.25μM CHIR99021 and 10μM Y-27632, cultured for 10 to 13 days. Upon completion of induction, the generation of colonies of renal progenitor cells could be confirmed (Figure 1A and figure 2 ).

[0104] In particular, it was confirmed that the combination of Yamanaka factor (Oct4, Klf4, Sox2, and c-Myc) to which Slug was added (5F: Oct4, Klf4, Sox2, c-Myc, and Slug) has excellent self-renewal ability and colony-forming ability (Figure 1B). However, male- and female-derived renal progenitor cells induced by the four-factor combination in which each facto...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for inducing direct reprogramming of urine cells into renal progenitor cells, and a pharmaceutical composition for preventing or treating renal cell injury diseases, comprising the renal progenitor cells reprogrammed by the method. The present invention can perform large-scale production of customized reprogrammed renal progenitor cells by using urine cells, a somatic cell that can be easily and repeatedly obtained without inconvenience and pain, and thus can be applied to the unfamiliar field that can be expanded to the field of renal injury treatment and kidney regeneration, and to the production of cell therapy products.

Description

technical field [0001] The present invention relates to a method for inducing direct reprogramming of urine cells into renal progenitor cells and a pharmaceutical composition for preventing or treating renal cell injury diseases comprising the renal progenitor cells reprogrammed by the above method. Background technique [0002] Stem cells are cells with unlimited potential for self-renewal or differentiation associated with specific cells and tissues required by the body. Stem cells are divided into three types: embryonic stem cells (ES cells) isolated from early embryos, embryonic germ cells (EG cells) isolated from embryonic primordial germ cells, and multipotent adult progenitor cells isolated from adult tissues (MAPC cells). [0003] Because of their potential to develop into cells with specialized functions, stem cells have been studied as cell therapy for the restoration of various organ functions and tissue regeneration, and recently, their applications have expande...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10A61K35/22A61P13/12
CPCA61P13/12A61K35/22C12N5/0687C12N2510/00C12N2506/25C12N2501/602C12N2501/603C12N2533/54C12N5/0686C12N2501/10C12N2501/155C12N2501/727C12N2501/91C12N2506/24C07K14/4705C12N15/86C12N2500/33C12N2501/119C12N2501/415C12N2533/90C12N2740/13043
Inventor 刘承权金仁勇高威威姜泌俊尹愿真朴圭万
Owner KOREA UNIV RES & BUSINESS FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com